treatment group:radiotherapy

5 trials

Sponsors

Sun Yat-sen University Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, The First Affiliated Hospital of Chengdu Medical College, Shanghai Chest Hhospital, The General Hospitol of JiLin Chemical Company

Conditions

Cervical cancerMetastatic brain carcinomasNon-small cell lung cancernasopharynx cancethymic tumors

Phase 2

T cell-based immunotherapy for advanced non-small cell lung cancer

Active, not recruitingChiCTR-ONRC-13003669

The General Hospitol of JiLin Chemical CompanyNon-small cell lung cancer

Start: 2013-11-01Updated: 2017-04-18

A prospective, single-arm, phase 2 clinical trial evaluating camrelizumab combined with induction chemotherapy, concurrent chemoradiotherapy and as maintenance therapy for locally advanced cervical cancer

Active, not recruitingChiCTR2200061097

Sun Yat-sen University Cancer CenterCervical cancer

Start: 2022-06-01Updated: 2023-03-26

Clinical trial of whole brain radiotherapy combined with stereotactic radiotherapy for metastatic brain carcinomas

Active, not recruitingChiCTR2400084295

The First Affiliated Hospital of Chengdu Medical CollegeMetastatic brain carcinomas

Start: 2024-05-20Updated: 2024-05-21

Phase 3

An open-label, prospective, randomized, multicenter, non-inferiority phase III clinical trial of selective IB lymph node radiotherapy for nasopharyngeal carcinoma

Active, not recruitingChiCTR2300072422

Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciencesnasopharynx cance

Start: 2023-07-01Updated: 2023-06-18

Unknown Phase

A prospective randomized study of completely resected invasive thymic tumors with or without postoperative radiotherapy

Active, not recruitingChiCTR-INR-16009526

Shanghai Chest Hhospitalthymic tumors

Start: 2017-01-01Updated: 2017-04-18

Related Papers

Neoadjuvant chemo-immunotherapy following concurrent immuno-chemoradiotherapy and immune-maintenance therapy as primary treatment for locally advanced cervical cancer: A prospective, single-arm, phase 2 trial.

Journal of Clinical Oncology2024-06-011 citations